
No results matched your search
GENEVA (Reuters) - The COVAX vaccine facility has delivered nearly 38.4 million doses of COVID-19 vaccines to more than 100 countries and economies across six continents as of Thursday, six weeks after it began to roll out supplies, a statement said.
Despite being hit by reduced supply availability in March and April, and higher demand in India where much of its main jab AstraZeneca (NASDAQ:AZN) is made, it expects to deliver doses to all economies that have requested them in the first half of 2021, the GAVI vaccine alliance and World Health Organization said.
"According to its latest supply forecast, COVAX expects to deliver at least 2 billion doses of vaccines in 2021," it said. Its portfolio, currently relying on AstraZeneca and the Pfizer (NYSE:PFE) and BioNTech shots, would be diversified.
By David French (Reuters) -The S&P 500 and Dow Jones industrial average ended lower on Monday, with investors waiting for cues from the upcoming corporate earnings season and a...
By Jonathan Stempel (Reuters) - A U.S. appeals court said a man who created a mayonnaise-ketchup blend he called "Metchup" cannot sue Kraft Heinz (NASDAQ:KHC) Co for selling a...
By Liz Moyer Investing.com -- Earnings season kicks off in high gear this week, and Wall Street is hanging on what executives describe as the outlook for the next few months. These...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.